Qiong Liu

Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then.

Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then.